EFA News 68.32 05/01/2014 04:48:53 EAFE Index MSCI Ishares (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
EAFE Index MSCI Ishares (EFA) 68.32 $EFA

Knowing ETF Firms' Traits Can Help You Sort Field
at Investor's Business Daily - Thu Apr 17, 5:15PM CDT
In the world of ETFs, there are large ETF issuers and there are tiny ones. Aside from looking at the asset size and the availability of a particular ETF that fits an investor's strategy, one needs to consider other differentiating factors among ETF...

Watch for iShares MSCI EAFE Index Fund to Potentially Pullback After Gaining 1.24% Yesterday
Comtex SmarTrend(R) - Wed Apr 16, 3:46PM CDT
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $66.73 to a high of $67.21. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $66.76 on volume of 19.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares MSCI EAFE Index Fund Set to Possibly Rebound After Yesterday's Selloff of 1.77%
Comtex SmarTrend(R) - Thu Apr 10, 3:44PM CDT
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $66.60 to a high of $67.62. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $66.73 on volume of 23.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Woof! New ETF Applies Dogs of Dow Theory to Emerging Markets
at The Street - Thu Apr 03, 9:49AM CDT
ALPS' new Emerging Sector Dividend Dogs ETF offers yield and diversification.

First Week Of March 2015 Options Trading For IShares MSCI EAFE Index Fund (EFA)
at The Street - Wed Mar 26, 9:55AM CDT
Investors in iShares MSCI EAFE Index Fund saw new options begin trading this week, for the March 2015 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 359 days until expiration...

SmarTrend Watching for Potential Pullback in Shares of iShares MSCI EAFE Index Fund After 1.09% Gain
Comtex SmarTrend(R) - Tue Mar 25, 3:43PM CDT
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $65.63 to a high of $66.19. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $65.81 on volume of 20.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Watch for iShares MSCI EAFE Index Fund to Potentially Rebound After Falling 1.86% Yesterday
Comtex SmarTrend(R) - Thu Mar 13, 3:42PM CDT
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $65.14 to a high of $66.69. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $66.01 on volume of 35.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

EFA May 2nd Options Begin Trading
at The Street - Thu Mar 13, 10:50AM CDT
Investors in iShares MSCI EAFE Index Fund saw new options begin trading today, for the May 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EFA options chain for the new May 2nd contracts and identified one...

iShares MSCI EAFE Index Fund Falls 2.12% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Mar 03, 3:50PM CST
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $65.91 to a high of $66.54. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $66.85 on volume of 27.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

NorthCoast ETF Retirement Portfolios End February On A High Note
at Investor's Business Daily - Fri Feb 28, 5:39PM CST
NorthCoast Asset Management saw its ETF retirement portfolios heat up in February, with all holdings ending the month higher. After an icy start to 2014, top holdings have caught fire. The S&P 500 pushed to record heights during the month and...

Ukraine's Lesson for Investors: Know What's in Your ETFs
at The Street - Mon Feb 24, 10:02AM CST
Many ETFs have overly large exposures that can create headaches for their holders.

3 Foreign Small Cap ETFs Likely to Outperform - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 9:00AM CST
While foreign large cap ETFs have struggled, these are looking quite solid right now.

Inside the New Currency Hedged ETFs from iShares - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Thu Feb 13, 1:00PM CST
iShares is now getting in on the currency hedged ETF market, launching three funds in the space.

iShares Launches Currency Hedged ETFs
Business Wire - Tue Feb 04, 7:00AM CST
--Benchmarked to the MSCI indexes, long considered a leader in international indexing

Look for Shares of iShares MSCI EAFE Index Fund to Potentially Rebound after Yesterday's 2.74% Sell Off
Comtex SmarTrend(R) - Fri Jan 24, 3:54PM CST
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $64.85 to a high of $65.70. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $66.41 on volume of 25.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 115

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 87

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Rutter Mills Expands Turkey Giveaway to Two Cities

Updated Category News Views 101

An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 194

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 77

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
CassTime's AI Solution Eases Global Parts Market Strains

Updated Category News Views 130

Driving Innovation in the Auto Aftermarket When car parts become a global jigsaw puzzle, you need more than wrenches to solve it. Enter CassTime with its AI-driven 'T+D Solution'—a tangible answer to the woes of data matching and repair capability bottlenecks plaguing the automotive aftermarket worldwide. Taming the Global Parts Beast Pull back the curtain on AAPEX 2026...

Continue Reading
Sensitron's 270VDC SSPCs: A Power System Shake-Up

Updated Category News Views 159

Revolutionizing Power Distribution with Sensitron Some days, the tech world dishes out real game-changers, and looks like November 6, 2026, was one of those days. Sensitron Semiconductor dropped a bombshell with their SPHM/SEHM Series—a brand-new lineup of programmable 16-channel Solid State Power Controllers (SSPCs). Tailored for the grueling demands of 270VDC power...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 154

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 180

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading

Top 5 Most Recently Viewed Articles

GigaCloud Technology's Continued Success on Forbes List 2026

Updated Category News Views 308

GigaCloud Technology Inc Shines on Forbes’ Small-Cap Companies List GigaCloud Technology Inc (Nasdaq: GCT) has once again earned a distinguished spot on Forbes’ notable list of America’s Most Successful Small-Cap Companies. This recognition reflects the Company’s ongoing commitment to innovation within its sector, marking an important milestone as they’ve been...

Continue Reading
Harvia Plc: Key Insights on the Upcoming AGM and Governance

Updated Category News Views 254

Invitation to Harvia Plc's Annual General Meeting Harvia Plc has extended an invitation to its shareholders for the upcoming Annual General Meeting. This event is crucial for stakeholders as it will shape the direction of the company for the coming fiscal year. Highlights of the Meeting Agenda The Annual General Meeting (AGM) will encompass various significant topics...

Continue Reading
Rokmaster's Closing of Second Funding Tranche Strengthens Future Exploration

Updated Category News Views 206

Rokmaster Resources Corp. Completes Final Funding Round Rokmaster Resources Corp. (TSXV: RKR) (OTCQB: RKMSF) is delighted to announce that it has successfully completed the final tranche of its flow-through financing. This financing initiative is crucial for the company as it enhances its capability to explore and develop its mining properties effectively. Details of the...

Continue Reading
Industrial Logistics Properties Trust Shares Q3 2024 Financials

Updated Category News Views 92

Industrial Logistics Properties Trust Shares Q3 2024 Financials Industrial Logistics Properties Trust (NASDAQ: ILPT) has recently announced its financial performance for the quarter ending September 30, 2024. This quarterly report sheds light on the company's operational and financial health, vital for current and prospective investors. Key Highlights and Financial...

Continue Reading
Cocrystal Pharma's CDI-988 Targets Viral Infections with Promise

Updated Category News Views 133

Cocrystal Pharma, Inc. is making waves in the biotech ocean with its oral pan-viral protease inhibitor, CDI-988. This bad boy recently entered the multiple-ascending dose (MAD) phase of a Phase 1 clinical study, a crucial milestone for evaluating both efficacy and safety as it aims to knock out viral infections broadly. With topline results expected to drop in late 2024...

Continue Reading